Atazanavir (BMS-232632) 是一种高选择性的HIV-1蛋白酶抑制剂，用于艾滋病毒感染的研究。Atazanavir 是CYP3A4的底物和抑制剂，也是P-糖蛋白的抑制剂和诱导剂。Atazanavir 也是SARS-CoV 3CLpro的抑制剂，IC50为 3.49 μM。
| 生物活性 | Atazanavir (BMS-232632), a highly selectiveHIV-1proteaseinhibitor, is the first protease inhibitor approved for once-daily administration[1]. Atazanavir (BMS-232632) is a substrate and inhibitor ofCYP3A4, and an inhibitor and inducer ofP-glycoprotein(P-gp)[2]. Atazanavir is also aSARS-CoV3CLproinhibitor with anIC50of 3.49 μM[3]. |
| IC50& Target | |
| Clinical Trial | |
| 分子量 | |
| Formula | |
| CAS 号 | |
| 中文名称 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
